Taurolidine group (n = 60) | Control group (n = 60) | p | |
---|---|---|---|
Duration of intervention (min) | |||
Colon | 206 (74) | 191 (53) | 0.39 |
Stomach | 259 (57) | 272 (102) | 0.57 |
Pancreas | 318 (58) | 371 (163) | 0.51 |
Perioperative mortality rate | 2 | 3 | 0.5 |
Colon | 1 | 0.5 | |
Stomach | 2 | 1 | 0.5 |
Pancreas | 1 | 0.5 | |
Perioperative morbidity rate | 17 | 20 | 0.35 |
Colon | 8 | 6 | 0.54 |
Stomach | 8 | 9 | 0.5 |
Pancreas | 3 | 0.12 | |
Surgery-related complications | 11 | 13 | 0.41 |
Anastomotic leak | 6 | 6 | - |
Peritonitis | 5 | 3 | 0.36 |
Intraperitoneal hemorrhage | 1 | - | |
Subcutaneous wound infection | 5 | 11 | 0.08 |
Non-surgery complications | 12 | 13 | 0.5 |
Myocardial infarction | 1 | 2 | 0.5 |
Transient cardiac arrhythmia | 4 | 6 | 0.37 |
Pneumonia/pleural effusion | 9 | 10 | 0.5 |
Acute renal failure | 1 | 3 | 0.31 |
Hepatic decompensation | 1 | 0.5 |